130 related articles for article (PubMed ID: 1670586)
1. Safety and effects of interleukin-2 plus zidovudine in asymptomatic individuals infected with human immunodeficiency virus.
Schwartz DH; Skowron G; Merigan TC
J Acquir Immune Defic Syndr (1988); 1991; 4(1):11-23. PubMed ID: 1670586
[TBL] [Abstract][Full Text] [Related]
2. Safety and efficacy of polyethylene glycol-modified interleukin-2 and zidovudine in human immunodeficiency virus type 1 infection: a phase I/II study.
Wood R; Montoya JG; Kundu SK; Schwartz DH; Merigan TC
J Infect Dis; 1993 Mar; 167(3):519-25. PubMed ID: 8095058
[TBL] [Abstract][Full Text] [Related]
3. A phase I/II trial of zidovudine, interferon-alpha, and granulocyte-macrophage colony-stimulating factor in the treatment of human immunodeficiency virus type 1 infection.
Davey RT; Davey VJ; Metcalf JA; Zurlo JJ; Kovacs JA; Falloon J; Polis MA; Zunich KM; Masur H; Lane HC
J Infect Dis; 1991 Jul; 164(1):43-52. PubMed ID: 1676045
[TBL] [Abstract][Full Text] [Related]
4. Safety and immunogenicity of a candidate therapeutic vaccine, p24 virus-like particle, combined with zidovudine, in asymptomatic subjects. Community HIV Research Network Investigators.
Kelleher AD; Roggensack M; Jaramillo AB; Smith DE; Walker A; Gow I; McMurchie M; Harris J; Patou G; Cooper DA
AIDS; 1998 Jan; 12(2):175-82. PubMed ID: 9468366
[TBL] [Abstract][Full Text] [Related]
5. Combined treatment of symptomatic human immunodeficiency virus type 1 infection with native interferon-alpha and zidovudine.
Berglund O; Engman K; Ehrnst A; Andersson J; Lidman K; Akerlund B; Sönnerborg A; Strannegård O
J Infect Dis; 1991 Apr; 163(4):710-5. PubMed ID: 1672701
[TBL] [Abstract][Full Text] [Related]
6. High-level viremia in adults and children infected with human immunodeficiency virus: relation to disease stage and CD4+ lymphocyte levels.
Saag MS; Crain MJ; Decker WD; Campbell-Hill S; Robinson S; Brown WE; Leuther M; Whitley RJ; Hahn BH; Shaw GM
J Infect Dis; 1991 Jul; 164(1):72-80. PubMed ID: 1676046
[TBL] [Abstract][Full Text] [Related]
7. T activation marker evaluation in ARC patients treated with AZT. Comparison with CD4+ lymphocyte count in non-progressors and progressors towards AIDS.
Levacher M; Tallet S; Dazza MC; Dournon E; Rouveix B; Pocidalo JJ
Clin Exp Immunol; 1990 Aug; 81(2):177-82. PubMed ID: 1696859
[TBL] [Abstract][Full Text] [Related]
8. Zidovudine-interferon-alpha combination therapy in patients with advanced human immunodeficiency virus type 1 infection: biphasic response of p24 antigen and quantitative polymerase chain reaction.
Edlin BR; Weinstein RA; Whaling SM; Ou CY; Connolly PJ; Moore JL; Bitran JD
J Infect Dis; 1992 May; 165(5):793-8. PubMed ID: 1349031
[TBL] [Abstract][Full Text] [Related]
9. Combination therapy with zidovudine and dideoxycytidine in patients with advanced human immunodeficiency virus infection. A phase I/II study.
Meng TC; Fischl MA; Boota AM; Spector SA; Bennett D; Bassiakos Y; Lai SH; Wright B; Richman DD
Ann Intern Med; 1992 Jan; 116(1):13-20. PubMed ID: 1345755
[TBL] [Abstract][Full Text] [Related]
10. Zidovudine in asymptomatic human immunodeficiency virus infection. A controlled trial in persons with fewer than 500 CD4-positive cells per cubic millimeter. The AIDS Clinical Trials Group of the National Institute of Allergy and Infectious Diseases.
Volberding PA; Lagakos SW; Koch MA; Pettinelli C; Myers MW; Booth DK; Balfour HH; Reichman RC; Bartlett JA; Hirsch MS
N Engl J Med; 1990 Apr; 322(14):941-9. PubMed ID: 1969115
[TBL] [Abstract][Full Text] [Related]
11. A pilot study of low-dose zidovudine in human immunodeficiency virus infection.
Collier AC; Bozzette S; Coombs RW; Causey DM; Schoenfeld DA; Spector SA; Pettinelli CB; Davies G; Richman DD; Leedom JM
N Engl J Med; 1990 Oct; 323(15):1015-21. PubMed ID: 1977080
[TBL] [Abstract][Full Text] [Related]
12. Long-term zidovudine treatment of asymptomatic HIV-1-infected subjects.
Mulder JW; de Wolf F; Goudsmit J; Cload PA; Coutinho RA; Fiddian AP; Schellekens PT; van der Noordaa J; Lange JM
Antiviral Res; 1990 Mar; 13(3):127-38. PubMed ID: 1972321
[TBL] [Abstract][Full Text] [Related]
13. Immune activation markers and AIDS prognosis.
Osmond DH; Shiboski S; Bacchetti P; Winger EE; Moss AR
AIDS; 1991 May; 5(5):505-11. PubMed ID: 1677808
[TBL] [Abstract][Full Text] [Related]
14. Response of serum p24 antigen and antibody to p24 antigen in patients with AIDS and AIDS-related complex treated with zidovudine.
Williams IG; Gabriel G; Kelly G; Loveday C; Tedder RS; Weller IV
AIDS; 1990 Sep; 4(9):909-12. PubMed ID: 2123627
[TBL] [Abstract][Full Text] [Related]
15. Circulating human immunodeficiency virus (HIV) p24 antigen-positive lymphocytes: a flow cytometric measure of HIV infection.
Ohlsson-Wilhelm BM; Cory JM; Kessler HA; Eyster ME; Rapp F; Landay A
J Infect Dis; 1990 Nov; 162(5):1018-24. PubMed ID: 1977803
[TBL] [Abstract][Full Text] [Related]
16. Zidovudine plus interferon-alpha versus zidovudine alone in HIV-infected symptomatic or asymptomatic persons with CD4+ cell counts > 150 x 10(6)/L: results of the Zidon trial. Zidon Study Group.
Fernández-Cruz E; Lang JM; Frissen J; Furner V; Châteauvert M; Boucher CA; Dowd P; Stevens J
AIDS; 1995 Sep; 9(9):1025-35. PubMed ID: 8527074
[TBL] [Abstract][Full Text] [Related]
17. In vivo additive antiretroviral effect of combined zidovudine and foscarnet therapy for human immunodeficiency virus infection (ACTG Protocol 053).
Jacobsen MA; van der Horst C; Causey DM; Dehlinger M; Hafner R; Mills J
J Infect Dis; 1991 Jun; 163(6):1219-22. PubMed ID: 1828075
[TBL] [Abstract][Full Text] [Related]
18. Zidovudine treatment of an infant with congenital human immunodeficiency virus infection.
Millard DD; Chadwick EG; Yogev R; Modlin JF
Pediatr Infect Dis J; 1990 Dec; 9(12):929-31. PubMed ID: 2126136
[No Abstract] [Full Text] [Related]
19. Predicting progression to AIDS: combined usefulness of CD4 lymphocyte counts and p24 antigenemia.
MacDonell KB; Chmiel JS; Poggensee L; Wu S; Phair JP
Am J Med; 1990 Dec; 89(6):706-12. PubMed ID: 1979205
[TBL] [Abstract][Full Text] [Related]
20. Augmentation of cellular immune function during the early phase of zidovudine treatment of AIDS patients.
Rinaldo C; Huang XL; Piazza P; Armstrong J; Rappocciolo G; Pazin G; McMahon D; Gupta P; Fan Z; Zhang Z
J Infect Dis; 1991 Oct; 164(4):638-45. PubMed ID: 1680135
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
